Emerging findings propose that Retatrutide , a dual agonist targeting gut hormone and GIP pathways , may represent a significant breakthrough for weight control . Early clinical trials shown https://getretatrutideaustralia.com/blog/retatrutide-weight-loss-revolution-2026